Bristol Myers adds on at Cambridge Crossing, settling in even further in bustling Boston-area biotech hub
In the summer of 2020, Bristol Myers Squibb unveiled plans to plant its flag in the bustling biopharma Cambridge Crossing campus on the border of Cambridge, Boston and neighboring Somerville. Now, the Big Pharma is doubling down on that move and giving itself a little extra elbow room to boot.
Last week, BMS expanded its lease to include the remaining eighth and ninth floors of its building at Cambridge Crossing, a move that ensures “future flexibility,” the company said in a statement to Endpoints News.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.